These eligibility criteria include a BMI of at least 30 or a BMI of at least 27 with weight-related comorbidities, such as hypertension, type 2 diabetes, OSA, or high cholesterol, and previous participation in a structured weight management program
The formula targets hepatic fat metabolism and energy production, commonly marketed for weight management and fatigue support
By: Kristin Brooks Managing Editor, Contract Pharma Ascendis Pharma has granted Novo Nordisk an exclusive worldwide license to the TransCon technology platform to develop, manufacture and commercialize Novo Nordisk products in metabolic diseases (including obesity and type 2 diabetes) and a product-by-product exclusive license in cardiovascular diseases
SunJFuJLiLChenCWangHHouYet al
Some people choose to supplement their body with extra L-Carnitine to ensure their body has a strong supply of L-Carnitine throughout the day